The modern pharmacopoeia: A return to depressive realism?

Bipolar Disorders

Volumn 10, Issue 8, 2008, Pages 969-972

  Goldberg, Joseph F ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b SILVER HILL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; CARBAMAZEPINE; DESIPRAMINE; FLUOXETINE; GABAPENTIN; IMIPRAMINE; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; OLANZAPINE; OXCARBAZEPINE; PAROXETINE; PLACEBO; QUETIAPINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TOPIRAMATE; VALPROATE SEMISODIUM; VENLAFAXINE;

BIPOLAR DEPRESSION; CLINICAL TRIAL; COMORBIDITY; DEPRESSION; DRUG EFFICACY; ELECTROCONVULSIVE THERAPY; HUMAN; LONG TERM CARE; MAINTENANCE THERAPY; MANIA; MEDICAL LITERATURE; MONOTHERAPY; NOTE; PRIORITY JOURNAL; PSYCHOTHERAPY; SUICIDE; TREATMENT DURATION; TREATMENT RESPONSE;

ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BIPOLAR DISORDER; CHRONIC DISEASE; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; HUMANS; LONG-TERM CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; RISK FACTORS; TREATMENT OUTCOME;

EID: 56349136387     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2008.00632.x     Document Type: Note

References (24)

1. Ghaemi SN. Why antidepressants are not antidepressants: STEP-BD, STAR*D and the return of neurotic depression. Bipolar Disord 2008; 10: 957-968.
2. Sachs GS, Nierenberg AA, Calabrese JR et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med 2007; 356: 1711-1722.
3. Kushner SF, Khan A, Lane R, Olson WH. Topiramate monotherapy in the management of acute mania: Results of four double-blind placebo-controlled trials. Bipolar Disord 2006; 8: 15-27.
4. Wagner KD, Kowatch RA, Emslie GJ et al. A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents. Am J Psychiatry 2006; 163: 1179-1186.
5. Pande AC, Crockatt JG, Janney CA, Werth JL, Tsaroucha G. Gabapentin in bipolar disorder: A placbo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group. Bipolar Disord 2000; 2: 249-255.
6. Geddes JR, Burgess S, Hawton K, Jamison K, Goodwin GM. Long-term lithium therapy for bipolar disorder: Systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry 2004; 161: 217-222.
7. Nierenberg AA, Fava M, Trivedi MH et al. A comparison of lithium and T(3) augmentation followed two failed medication treatments for depression: A STAR*D report. Am J Psychiatry 2006; 163: 1519-1530.
8. 5Gyulai L, Bowden CL, McElroy SL et al. Maintenance efficacy of divalproex in the prevention of bipolar depression. Neuropsychopharmacol 2003; 28: 1374-1382.
9. Tohen M, Calabrese JR, Sachs GS et al. Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine. Am J Psychiatry 2006; 163: 247-256.
10. Keck PE Jr, Calabrese JR, McIntyre RS et al. Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: A 100-week, double-blind study versus placebo. J Clin Psychiatry 2007; 68: 1480-1491.
11. Trivedi MH, Rush AJ, Wisniewski SR et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006; 163: 28-40.
12. Rush AJ. STAR*D: What have we learned? Am J Psychiatry 2007; 164: 201-204.
13. Zimmerman M, Chelminski I, Posternak MA. Generalizability of antidepressant efficacy trials: Differences between depressed psychiatric outpatients who would or would not qualify for an efficacy trial. Am J Psychiatry 2005; 162: 1370-1372.
14. Koran LM, Gelenberg AJ, Kornstein SG et al. Sertraline versus imipramine to prevent relapse in chronic depression. J Affect Disord 2001; 65: 27-36.
15. Harrow M, Goldberg JF, Grossman LS, Meltzer HY. Outcome in manic disorders: A naturalistic follow-up study. Arch Gen Psychiatry 1990; 47: 665-671.
16. Gitlin MJ, Swendsen J, Heller TL, Hammen C. Relapse and impairment in bipolar disorder. Am J Psychiatry 1995; 152: 1635-1640.
17. Dickson WE, Kendell RE. Does maintenance lithium therapy prevent recurrences of mania under ordinary clinical conditions? Psychol Med 1986; 16: 521-530.
18. Markar HR, Mander AJ. Efficacy of lithium in clinical practice. Br J Psychiatry 1989; 155: 496-500.
19. Gibbons RD, Hur K, Bhaumik DK, Mann JJ. The relationship between antidepressant medication use and rate of suicide. Arch Gen Psychiatry 2005; 62: 165-172.
20. Grunebaum MF, Ellis SP, Li S, Oquendo MA, Mann JJ. Antidepressants and suicide risk in the United States, 1985-1999. J Clin Psychiatry 2004; 65: 1456-1462.
21. Olfson M, Shaffer D, Marcus SC, Greenberg T. Relationship between antidepressant medication treatment and suicide in adolescents. Arch Gen Psychiatry 2003; 60: 978-982.
22. Isacsson G, Holmgren P, Ahlner J. Selective serotonin reuptake inhibitor antidepressants and the risk of suicide: A controlled forensic database study of 14,857 suicides. Acta Psychiatr Scand 2005; 111: 286-290.
23. Angst F, Stassen HH, Clayton PJ, Angst J. Mortality of patients with mood disorders: Follow-up over 34-38 years. J Affect Disord 2002; 68: 167-181.
24. Isacsson G, Holmgren P, Wasserman D, Bergman U. Use of antidepressants among people committing suicide in Sweden. BMJ 1994; 308: 506-509.